Citing scientific and humanitarian grounds, Mind Medicine Australia is urging the Therapeutic Goods Administration to reverse its interim decision to block the legal availability of psilocybin and MDMA as controlled medicines.
Last week the Therapeutic Goods Administration announced its interim decision not to reschedule medical grade psilocybin and MDMA for medical use, but Mind Medicine Australia is going to contest the decision.
Mind Medicine Australia’s Tania de Jong AM and Peter Hunt AM recently spoke in a public webinar about the emerging role of psychedelics in mental health treatment.